Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Montpellier
Secondary objectives:
* To describe the initial one-year changes in health resource use before and after the initiation of mepolizumab treatment
* To further characterize rates of change in health resource usage and/or costs in subpopulations of interest (sex, age groups, severe asthma, uncontrolled asthma, COPD, diabetes)
This retrospective, non-interventional (not involving human subjects) database study will compare real-life patient health resource consumption before versus after a first injection of mepolizumab. Data concerning patients receiving mepolizumab will be collated for a 12-month period (the "baseline period") preceding a first index treatment (at "T0") and compared to a 12-month period occurring after the index treatment (the "exposure period").
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Beneficiary in the anonymous French national SNDS database
The beneficiary received mepolizumab
You may not be if
Health resource use data covering the 12 months preceding the first filled prescription for mepolizumab are not available
Health resource use data covering the time period starting at the first filled prescription for mepolizumab and ending at subsequent death or at 12 months later are not available